INBX in the 13F filings
Inhibrx Biosciences Inc · CUSIP 45720N103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 4 listed it in both
- Shares listed
- 3,283,590
- combined, among listed positions
- Reported value
- $221m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 12 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -9,130.
Managers listing INBX in Q1 2026
22 of 22 holders
Largest increases and reductions, by shares
Increases
- Woodline Partners LPexisting position · 384,433 shares now+244,954
- Millennium Management LLCexisting position · 327,860 shares now+51,943
- Schonfeld Strategic Advisors LLCexisting position · 254,827 shares now+40,102
- ExodusPoint Capital Management LPnew position · 30,980 shares now+30,980
- Voloridge Investment Management LLCnew position · 13,501 shares now+13,501
Reductions
- Susquehanna International Group LLPexisting position · 97,873 shares now-199,243
- Invesco Ltdexisting position · 23,356 shares now-89,040
- D. E. Shaw & Co.existing position · 77,437 shares now-44,664
- Capital Research Global Investorsexisting position · 392,847 shares now-28,728
- Jane Street Group LLCexisting position · 9,196 shares now-23,823
New positions and exits
New (3)
Exited (1)
- Acadian Asset Management LLCwas $2.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2024 | 1 | $25m | 1 | 0 |
| Q3 2024 | 1 | $28m | 0 | 0 |
| Q4 2024 | 1 | $28m | 0 | 0 |
| Q1 2025 | 1 | $25m | 0 | 0 |
| Q2 2025 | 2 | $35m | 1 | 0 |
| Q3 2025 | 2 | $72m | 0 | 1 |
| Q4 2025 | 4 | $175m | 12 | 9 |
| Q1 2026 | 4 | $166m | 12 | 9 |
| Q2 2026 | 4 | $245m | 12 | 14 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
INBX and GILD →INBX and AMGN →INBX and ARGX →Choose a stock to compare with INBX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own INBX, latest filings →Back to the 13F Explorer →